Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 October 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 190 pages)

 

Export 14 results:
Author Title [ Type(Asc)] Year
Filters: Author is Rietbrock, S.  [Clear All Filters]
Journal Article
C. Martinez, Jones, R. W., and Rietbrock, S., Trends in the prevalence of antipsychotic drug use among patients with Alzheimer's disease and other dementias including those treated with antidementia drugs in the community in the UK: a cohort study, BMJ Open, vol. 3, 2013.
C. Martinez, Katholing, A., Folkerts, K., and Rietbrock, S., Thirteen-year trend in the persistence with vitamin K antagonists for venous thromboembolism in the UK: a cohort study, Curr Med Res Opin, vol. 34, pp. 1985-1990, 2018.
C. Martinez, Suissa, S., Rietbrock, S., Katholing, A., Freedman, B., Cohen, A. T., and Handelsman, D. J., Testosterone treatment and risk of venous thromboembolism: population based case-control study, Bmj, vol. 355, p. i5968, 2016.
B. Freedman, Martinez, C., Katholing, A., and Rietbrock, S., Residual Risk of Stroke and Death in Anticoagulant-Treated Patients With Atrial Fibrillation, JAMA Cardiol, vol. 1, pp. 366-8, 2016.
S. Rietbrock, Olson, M., and van Staa, T. P., The potential effects on fracture outcomes of improvements in persistence and compliance with bisphosphonates, Qjm, vol. 102, pp. 35-42, 2009.
A. M. Gallagher, Rietbrock, S., Plumb, J., and van Staa, T. P., Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis?, J Thromb Haemost, vol. 6, pp. 1500-6, 2008.
V. Cairns, Wallenhorst, C., Rietbrock, S., and Martinez, C., Incidence of Lyme disease in the UK: a population-based cohort study, BMJ Open, vol. 9, p. e025916, 2019.
S. Rietbrock, Plumb, J. M., Gallagher, A. M., and van Staa, T. P., How effective are dose-adjusted warfarin and aspirin for the prevention of stroke in patients with chronic atrial fibrillation? An analysis of the UK General Practice Research Database, Thromb Haemost, vol. 101, pp. 527-34, 2009.
A. M. Gallagher, Rietbrock, S., Olson, M., and van Staa, T. P., Fracture outcomes related to persistence and compliance with oral bisphosphonates, J Bone Miner Res, vol. 23, pp. 1569-75, 2008.
A. T. Cohen, Katholing, A., Rietbrock, S., Bamber, L., and Martinez, C., Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study, Thromb Haemost, vol. 117, pp. 57-65, 2017.
C. Martinez, Cohen, A. T., Bamber, L., and Rietbrock, S., Epidemiology of first and recurrent venous thromboembolism: a population-based cohort study in patients without active cancer, Thromb Haemost, vol. 112, pp. 255-63, 2014.
T. P. van Staa, Rietbrock, S., Setakis, E., and Leufkens, H. G., Does the varied use of NSAIDs explain the differences in the risk of myocardial infarction?, J Intern Med, vol. 264, pp. 481-92, 2008.
S. Rietbrock, Heeley, E., Plumb, J., and Van Staa, T., Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme, Am Heart J, vol. 156, pp. 57-64, 2008.
C. Martinez, Rietbrock, S., Wise, L., Ashby, D., Chick, J., Moseley, J., Evans, S., and Gunnell, D., Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study, Bmj, vol. 330, p. 389, 2005.
[Page last reviewed 4 October 2019]